Tucson, AZ, United States of America

David S Alberts

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents, primarily in Medical Treatments. Top assignees: Cancer Technologies, Inc., Medimmune Oncology, Inc., Research Corporation Technologies, Inc.. Active years: 1987-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David S Alberts. Retrieved from https://idiyas.com/inventor/david-s-alberts

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.1

ph-index = 8

Forward Citations = 197(Granted Patents)


Company Filing History:


Years Active: 1987-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Vitamin D Production
Neuro-Disorders
Nephro-Disorders
Aminothiol Compounds
Tumor Measurement
Topical Treatments
Antineoplastic Compounds
Self-Sheathing Needle
HIV Deactivation
Chromatin Texture Mapping
DMSO Treatment
Aspiration Device
14 patents (USPTO):Explore Patents

Title: Innovations and Contributions of David S. Alberts

Introduction

David S. Alberts is a notable inventor based in Tucson, Arizona, recognized for his significant contributions to medical science and technology. With a total of 14 patents to his name, Alberts has made strides in enhancing health and wellness through innovative methods.

Latest Patents

One of his latest patents is a method for producing Vitamin D in a person. This method involves a source of Vitamin D, a sunlight exposure indicator, and sunscreen. The Vitamin D, such as cod liver oil, can be applied topically via a patch or towlette, or ingested orally. The exposure indicator is worn by the user and changes its state to indicate sunlight exposure for a predetermined period. After allowing sufficient time for Vitamin D absorption, the user can expose their skin to sunlight while monitoring the exposure indicator. Once the indicator changes state, the user applies sunscreen to their skin. Another significant patent involves methods for treating neuro-disorders using aminothiol compounds. This invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, also known as amifostine, and other aminothiol compounds. It aims to treat and reverse toxicities caused by therapeutic agents, radiation treatment, or diabetes, particularly focusing on neurotoxicity and nephrotoxicity associated with chemotherapeutic agents.

Career Highlights

Throughout his career, David S. Alberts has worked with various companies, including Topical Technologies, Inc. His innovative approaches have garnered attention and respect in the field of medical technology.

Collaborations

Alberts has collaborated with notable individuals such as Robert T. Dorr and Martin Stogniew, contributing to the advancement of his research and inventions.

Conclusion

David S. Alberts continues to be a prominent figure in the realm of innovation, particularly in medical advancements. His work not only reflects his expertise but also his commitment to improving health outcomes through inventive solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…